These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 29113987)

  • 21. BAP1 suppresses lung cancer progression and is inhibited by miR-31.
    Yu M; Liang H; Fu Z; Wang X; Liao Z; Zhou Y; Liu Y; Wang Y; Hong Y; Zhou X; Yan X; Yu M; Ma M; Zhang W; Guo B; Zhang J; Zen K; Zhang CY; Wang T; Zhang Q; Chen X
    Oncotarget; 2016 Mar; 7(12):13742-53. PubMed ID: 26885612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A 13-gene expression-based radioresistance score highlights the heterogeneity in the response to radiation therapy across HPV-negative HNSCC molecular subtypes.
    Foy JP; Bazire L; Ortiz-Cuaran S; Deneuve S; Kielbassa J; Thomas E; Viari A; Puisieux A; Goudot P; Bertolus C; Foray N; Kirova Y; Verrelle P; Saintigny P
    BMC Med; 2017 Sep; 15(1):165. PubMed ID: 28859688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. BAP1 links metabolic regulation of ferroptosis to tumour suppression.
    Zhang Y; Shi J; Liu X; Feng L; Gong Z; Koppula P; Sirohi K; Li X; Wei Y; Lee H; Zhuang L; Chen G; Xiao ZD; Hung MC; Chen J; Huang P; Li W; Gan B
    Nat Cell Biol; 2018 Oct; 20(10):1181-1192. PubMed ID: 30202049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
    Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
    J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer.
    Black M; Ghasemi F; Sun RX; Stecho W; Datti A; Meens J; Pinto N; Ruicci KM; Khan MI; Han MW; Shaikh M; Yoo J; Fung K; MacNeil D; Palma DA; Winquist E; Howlett CJ; Mymryk JS; Ailles L; Boutros PC; Barrett JW; Nichols AC
    Oral Oncol; 2020 Feb; 101():104529. PubMed ID: 31864959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L.
    Nathansen J; Lukiyanchuk V; Hein L; Stolte MI; Borgmann K; Löck S; Kurth I; Baumann M; Krause M; Linge A; Dubrovska A
    Oncogene; 2021 Jun; 40(24):4214-4228. PubMed ID: 34079088
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAP1/ASXL1 recruitment and activation for H2A deubiquitination.
    Sahtoe DD; van Dijk WJ; Ekkebus R; Ovaa H; Sixma TK
    Nat Commun; 2016 Jan; 7():10292. PubMed ID: 26739236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demethylation Therapy as a Targeted Treatment for Human Papillomavirus-Associated Head and Neck Cancer.
    Biktasova A; Hajek M; Sewell A; Gary C; Bellinger G; Deshpande HA; Bhatia A; Burtness B; Judson B; Mehra S; Yarbrough WG; Issaeva N
    Clin Cancer Res; 2017 Dec; 23(23):7276-7287. PubMed ID: 28916527
    [No Abstract]   [Full Text] [Related]  

  • 30. Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1.
    Lin YH; Liang Y; Wang H; Tung LT; Förster M; Subramani PG; Di Noia JM; Clare S; Langlais D; Nijnik A
    Front Immunol; 2021; 12():626418. PubMed ID: 33912157
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5.
    Qin J; Zhou Z; Chen W; Wang C; Zhang H; Ge G; Shao M; You D; Fan Z; Xia H; Liu R; Chen C
    Nat Commun; 2015 Sep; 6():8471. PubMed ID: 26419610
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.
    Arenzana TL; Lianoglou S; Seki A; Eidenschenk C; Cheung T; Seshasayee D; Hagenbeek T; Sambandam A; Noubade R; Peng I; Lesch J; DeVoss J; Wu X; Lee WP; Caplazi P; Webster J; Liu J; Pham VC; Arnott D; Lill JR; Modrusan Z; Dey A; Rutz S
    Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29678836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-31-5p alleviates septic cardiomyopathy by targeting BAP1 to inhibit SLC7A11 deubiquitination and ferroptosis.
    Liu Y; Hu N; Ai B; Xia H; Li W
    BMC Cardiovasc Disord; 2024 May; 24(1):286. PubMed ID: 38816686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SLC3A2/CD98hc, autophagy and tumor radioresistance: a link confirmed.
    Digomann D; Linge A; Dubrovska A
    Autophagy; 2019 Oct; 15(10):1850-1851. PubMed ID: 31276435
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The BAP1 nuclear deubiquitinase is involved in the nonhomologous end-joining pathway of double-strand DNA repair through interaction with DNA-PK.
    Sato H; Ito T; Hayashi T; Kitano S; Erdjument-Bromage H; Bott MJ; Toyooka S; Zauderer M; Ladanyi M
    Oncogene; 2024 Apr; 43(15):1087-1097. PubMed ID: 38383726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.
    Lee SW; Youn H; Kim EJ; Um SJ
    Mol Cell; 2013 Jul; 51(2):200-10. PubMed ID: 23850490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.
    Küry S; Ebstein F; Mollé A; Besnard T; Lee MK; Vignard V; Hery T; Nizon M; Mancini GMS; Giltay JC; Cogné B; McWalter K; Deb W; Mor-Shaked H; Li H; Schnur RE; Wentzensen IM; Denommé-Pichon AS; Fourgeux C; Verheijen FW; Faurie E; Schot R; Stevens CA; Smits DJ; Barr E; Sheffer R; Bernstein JA; Stimach CL; Kovitch E; Shashi V; Schoch K; Smith W; van Jaarsveld RH; Hurst ACE; Smith K; Baugh EH; Bohm SG; Vyhnálková E; Ryba L; Delnatte C; Neira J; Bonneau D; Toutain A; Rosenfeld JA; ; Audebert-Bellanger S; Gilbert-Dussardier B; Odent S; Laumonnier F; Berger SI; Smith ACM; Bourdeaut F; Stern MH; Redon R; Krüger E; Margueron R; Bézieau S; Poschmann J; Isidor B
    Am J Hum Genet; 2022 Feb; 109(2):361-372. PubMed ID: 35051358
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.
    Zumsteg ZS; Morse N; Krigsfeld G; Gupta G; Higginson DS; Lee NY; Morris L; Ganly I; Shiao SL; Powell SN; Chung CH; Scaltriti M; Baselga J
    Clin Cancer Res; 2016 Apr; 22(8):2009-19. PubMed ID: 26589432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.
    Vlashi E; Chen AM; Boyrie S; Yu G; Nguyen A; Brower PA; Hess CB; Pajonk F
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1198-206. PubMed ID: 27026319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.